Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B-cell-depleting therapy, is as effective as ocrelizumab in newly diagnosed relapsing multiple sclerosis ...
Jul 2, 2026
0
8









